Comments on: A Phase 2 Open-Label Study to Evaluate Safety and Clinical Activity of Etavopivat in Patients With Thalassemia or Sickle Cell Disease

Comments on: A Phase 2 Open-Label Study to Evaluate Safety and Clinical Activity of Etavopivat in Patients With Thalassemia or Sickle Cell Disease https://scdstudies.com/a-phase-2-open-label-study-to-evaluate-safety-and-clinical-activity-of-etavopivat-in-patients-with-thalassemia-or-sickle-cell-disease/?utm_source=rss&utm_medium=rss&utm_campaign=a-phase-2-open-label-study-to-evaluate-safety-and-clinical-activity-of-etavopivat-in-patients-with-thalassemia-or-sickle-cell-disease Sun, 23 Jun 2024 12:21:13 +0000 hourly 1 https://wordpress.org/?v=6.7.1